These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 32139740)

  • 1. Odontogenic infection by Porphyromonas gingivalis exacerbates fibrosis in NASH via hepatic stellate cell activation.
    Nagasaki A; Sakamoto S; Chea C; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
    Sci Rep; 2020 Mar; 10(1):4134. PubMed ID: 32139740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
    Ni XX; Li XY; Wang Q; Hua J
    J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elimination of Porphyromonas gingivalis inhibits liver fibrosis and inflammation in NASH.
    Nagasaki A; Sakamoto S; Arai T; Kato M; Ishida E; Furusho H; Fujii M; Takata T; Miyauchi M
    J Clin Periodontol; 2021 Oct; 48(10):1367-1378. PubMed ID: 34250613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dental infection of Porphyromonas gingivalis exacerbates high fat diet-induced steatohepatitis in mice.
    Furusho H; Miyauchi M; Hyogo H; Inubushi T; Ao M; Ouhara K; Hisatune J; Kurihara H; Sugai M; Hayes CN; Nakahara T; Aikata H; Takahashi S; Chayama K; Takata T
    J Gastroenterol; 2013 Nov; 48(11):1259-70. PubMed ID: 23307045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
    Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
    J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the combined impact of fatty liver-induced TGF-β1 and LPS-activated macrophages in fibrosis through a novel 3D serial section methodology.
    Ishiyama S; Hayatsu M; Toriumi T; Tsuda H; Watanabe K; Kasai H; Kishigami S; Mochizuki K; Mikami Y
    Sci Rep; 2024 May; 14(1):11404. PubMed ID: 38762616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor beta-1 upregulates glucose transporter 1 and glycolysis through canonical and noncanonical pathways in hepatic stellate cells.
    Zhou MY; Cheng ML; Huang T; Hu RH; Zou GL; Li H; Zhang BF; Zhu JJ; Liu YM; Liu Y; Zhao XK
    World J Gastroenterol; 2021 Oct; 27(40):6908-6926. PubMed ID: 34790014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Interplay Between Sonic Hedgehog and Transforming Growth Factor-β1 in Human Nonalcoholic Steatohepatitis.
    Zhou X; Wang P; Ma Z; Li M; Teng X; Sun L; Wan G; Li Y; Guo L; Liu H
    Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):154-160. PubMed ID: 32044884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-driven reduction of cytoglobin leads to oxidative DNA damage in stellate cells during non-alcoholic steatohepatitis.
    Okina Y; Sato-Matsubara M; Matsubara T; Daikoku A; Longato L; Rombouts K; Thanh Thuy LT; Ichikawa H; Minamiyama Y; Kadota M; Fujii H; Enomoto M; Ikeda K; Yoshizato K; Pinzani M; Kawada N
    J Hepatol; 2020 Oct; 73(4):882-895. PubMed ID: 32330605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Huangqi Decoction, a compound Chinese herbal medicine, inhibits the proliferation and activation of hepatic stellate cells by regulating the long noncoding RNA-C18orf26-1/microRNA-663a/transforming growth factor-β axis.
    Dong BS; Liu FQ; Yang WN; Li XD; Shi MJ; Li MR; Yan XL; Zhang H
    J Integr Med; 2023 Jan; 21(1):47-61. PubMed ID: 36456413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
    Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
    Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymosin β4 suppresses CCl
    Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
    J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1.
    Hong L; Shejiao D; Fenrong C; Gang Z; Lei D
    J Cell Mol Med; 2015 Oct; 19(10):2462-8. PubMed ID: 26249143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of TGF-β1-CD147 positive feedback loop in hepatic stellate cells promotes liver fibrosis.
    Li HY; Ju D; Zhang DW; Li H; Kong LM; Guo Y; Li C; Wang XL; Chen ZN; Bian H
    Sci Rep; 2015 Nov; 5():16552. PubMed ID: 26559755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Niemann-Pick Type C2 Protein Mediates Hepatic Stellate Cells Activation by Regulating Free Cholesterol Accumulation.
    Twu YC; Lee TS; Lin YL; Hsu SM; Wang YH; Liao CY; Wang CK; Liang YC; Liao YJ
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27420058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Geniposide inhibits hepatic fibrosis and hepatic stellate cell activation through blocking the TGF-β1/Smad signaling pathway].
    Zhou LH; Chen X
    Sheng Li Xue Bao; 2022 Apr; 74(2):217-224. PubMed ID: 35503069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PHP14 regulates hepatic stellate cells migration in liver fibrosis via mediating TGF-β1 signaling to PI3Kγ/AKT/Rac1 pathway.
    Xu A; Li Y; Zhao W; Hou F; Li X; Sun L; Chen W; Yang A; Wu S; Zhang B; Yao J; Wang H; Huang J
    J Mol Med (Berl); 2018 Feb; 96(2):119-133. PubMed ID: 29098317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morin attenuates diethylnitrosamine-induced rat liver fibrosis and hepatic stellate cell activation by co-ordinated regulation of Hippo/Yap and TGF-β1/Smad signaling.
    Perumal N; Perumal M; Halagowder D; Sivasithamparam N
    Biochimie; 2017 Sep; 140():10-19. PubMed ID: 28552397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine kinase receptor B attenuates liver fibrosis by inhibiting TGF-β/SMAD signaling.
    Song Y; Wei J; Li R; Fu R; Han P; Wang H; Zhang G; Li S; Chen S; Liu Z; Zhao Y; Zhu C; Zhu J; Zhang S; Pei H; Cheng J; Wu J; Dong L; Song G; Shen X; Yao Q
    Hepatology; 2023 Nov; 78(5):1433-1447. PubMed ID: 36800849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gentiopicroside improves NASH and liver fibrosis by suppressing TLR4 and NLRP3 signaling pathways.
    Yong Q; Huang C; Chen B; An J; Zheng Y; Zhao L; Peng C; Liu F
    Biomed Pharmacother; 2024 Aug; 177():116952. PubMed ID: 38917754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.